US Stock MarketDetailed Quotes

BGLC BioNexus Gene Lab

Watchlist

0.574
+0.004+0.68%

Close May 17 16:00 ET

0.569
-0.005-0.84%

Post 18:16 ET

10.14MMarket Cap-2958P/E (TTM)

BioNexus Gene Lab Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

70.44%-34.44K

-335.87%-1.3M

-154.94%-261.91K

-391.15%-899.35K

87.84%-23.82K

-207.93%-116.52K

5,923.60%551.82K

-1.30%476.74K

-2.21%308.89K

78.35%-195.97K

Net income from continuing operations

-50.23%-103.76K

-638.57%-2.63M

296.51%308.46K

-3,271.00%-2.61M

-86.97%-259.25K

-504.70%-69.07K

-147.36%-355.97K

-275.89%-156.97K

-126.21%-77.4K

-590.63%-138.66K

Operating gains losses

-73.95%-15.13K

46.78%-61.41K

84.86%-12.52K

-117.15%-29.1K

8.27%-11.09K

-20.28%-8.7K

-423.59%-115.38K

-865.70%-82.65K

-454.76%-13.4K

-20.26%-12.09K

Depreciation and amortization

18.97%29.59K

2.85%108.42K

13.81%29.66K

13.38%29.29K

-8.45%24.61K

-6.68%24.87K

-2.58%105.42K

-1.73%26.06K

-3.67%25.83K

-32.51%26.88K

Other non cash items

52.39%2.71K

13.90%8.88K

-8.36%2.08K

48.73%2.58K

--2.43K

--1.78K

--7.79K

--2.27K

--1.74K

----

Change In working capital

113.98%3.92K

-85.84%117.98K

-98.32%12.44K

-65.22%106.64K

119.88%26.91K

64.14%-28.01K

196.65%833.39K

104.40%740.15K

5,969.93%306.65K

86.33%-135.3K

-Change in receivables

-131.16%-105.67K

9.71%606.16K

7.83%72.59K

871.71%208.55K

-108.70%-14.03K

12.12%339.05K

-14.24%552.51K

-91.07%67.32K

108.15%21.46K

174.62%161.34K

-Change in inventory

-22.20%60.82K

-129.48%-160.39K

-125.30%-29.89K

-86.20%57.46K

-294.68%-266.14K

161.56%78.17K

257.37%544.11K

445.06%118.14K

93.20%416.26K

158.43%136.71K

-Change in payables and accrued expense

112.75%55.23K

-218.55%-381.29K

-102.57%-16.68K

-89.55%-253.51K

175.39%321.95K

-107.57%-433.06K

89.86%-119.7K

265.29%649.74K

-381.72%-133.74K

20.22%-427.07K

-Change in other current liabilities

-175.79%-12.04K

160.48%76.62K

95.10%-5.37K

1,696.16%93.01K

-7.74%-6.65K

12.80%-4.37K

-528.12%-126.69K

-2,431.20%-109.68K

-18.56%-5.83K

-35.83%-6.18K

-Change in other working capital

171.50%5.58K

-37.20%-23.12K

-156.19%-8.22K

-86.77%1.12K

-7,589.72%-8.23K

80.43%-7.8K

-142.16%-16.85K

--14.63K

--8.5K

---107

Cash from discontinued investing activities

Operating cash flow

70.44%-34.44K

-335.87%-1.3M

-154.94%-261.91K

-391.15%-899.35K

87.84%-23.82K

-207.93%-116.52K

5,923.60%551.82K

-1.30%476.74K

-2.21%308.89K

78.35%-195.97K

Investing cash flow

Cash flow from continuing investing activities

576.62%24.1K

15.08%-382.58K

72.44%-13.75K

-2,064.65%-360.71K

98.62%-3.06K

97.44%-5.06K

8.17%-450.5K

34.59%-49.9K

131.34%18.36K

-270.45%-221.82K

Net PPE purchase and sale

-21,414.71%-21.95K

-175.79%-149.4K

94.50%-937

-3,561.28%-134K

-1,010.29%-14.36K

99.68%-102

-1,613.19%-54.17K

-1,231.27%-17.03K

-792.68%-3.66K

-94.14%-1.29K

Net investment purchase and sale

371.85%37.1K

42.43%-294.59K

77.73%-25.33K

-3,851.44%-255.81K

100.09%202

92.07%-13.65K

-0.44%-511.71K

-36.09%-113.73K

111.26%6.82K

-235.83%-232.62K

Cash from discontinued investing activities

Investing cash flow

576.62%24.1K

15.08%-382.58K

72.44%-13.75K

-2,064.65%-360.71K

98.62%-3.06K

97.44%-5.06K

8.17%-450.5K

34.59%-49.9K

131.34%18.36K

-270.45%-221.82K

Financing cash flow

Cash flow from continuing financing activities

1,461.38%24.22K

5,219.80%5.75M

589.05%11.12K

331,172.47%5.75M

-2.43K

-1.78K

483.28%108.17K

54.16%-2.27K

71.45%-1.74K

Net issuance payments of debt

----

--0

----

-29.41%-34.04K

--0

----

Net common stock issuance

----

--5.75M

----

--0

----

Cash dividends paid

--0

----

Net other financing activities

--26.93K

3,742.13%5.76M

----

7,912.50%150K

----

Cash from discontinued financing activities

Financing cash flow

1,461.38%24.22K

5,219.80%5.75M

589.05%11.12K

331,172.47%5.75M

---2.43K

---1.78K

483.28%108.17K

54.16%-2.27K

71.45%-1.74K

----

Net cash flow

Beginning cash position

179.84%5.93M

-0.24%2.12M

320.37%6.15M

31.21%1.76M

6.99%1.97M

-0.24%2.12M

-23.81%2.12M

-14.00%1.46M

-9.60%1.34M

-25.47%1.84M

Current changes in cash

111.25%13.88K

1,842.87%4.07M

-162.31%-264.55K

1,278.54%4.49M

90.41%-29.31K

47.50%-123.35K

141.11%209.49K

5.68%424.56K

29.58%325.52K

68.61%-305.61K

Effect of exchange rate changes

-397.91%-111.03K

-21.04%-259.68K

-79.75%47K

51.29%-99.16K

6.63%-185.22K

50.03%-22.3K

-39.19%-214.55K

966.13%232.03K

-507.38%-203.58K

-984.03%-198.38K

End cash Position

195.57%5.83M

179.84%5.93M

320.37%6.15M

31.21%1.76M

6.99%1.97M

-0.24%2.12M

-14.00%1.46M

-9.60%1.34M

Free cash flow

51.65%-56.39K

-391.57%-1.45M

-157.18%-262.85K

-438.55%-1.03M

80.65%-38.18K

-66.53%-116.62K

8,195.57%497.65K

-4.57%459.71K

-3.24%305.23K

78.22%-197.26K

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	70.44%-34.44K	-335.87%-1.3M	-154.94%-261.91K	-391.15%-899.35K	87.84%-23.82K	-207.93%-116.52K	5,923.60%551.82K	-1.30%476.74K	-2.21%308.89K	78.35%-195.97K
Net income from continuing operations	-50.23%-103.76K	-638.57%-2.63M	296.51%308.46K	-3,271.00%-2.61M	-86.97%-259.25K	-504.70%-69.07K	-147.36%-355.97K	-275.89%-156.97K	-126.21%-77.4K	-590.63%-138.66K
Operating gains losses	-73.95%-15.13K	46.78%-61.41K	84.86%-12.52K	-117.15%-29.1K	8.27%-11.09K	-20.28%-8.7K	-423.59%-115.38K	-865.70%-82.65K	-454.76%-13.4K	-20.26%-12.09K
Depreciation and amortization	18.97%29.59K	2.85%108.42K	13.81%29.66K	13.38%29.29K	-8.45%24.61K	-6.68%24.87K	-2.58%105.42K	-1.73%26.06K	-3.67%25.83K	-32.51%26.88K
Other non cash items	52.39%2.71K	13.90%8.88K	-8.36%2.08K	48.73%2.58K	--2.43K	--1.78K	--7.79K	--2.27K	--1.74K	----
Change In working capital	113.98%3.92K	-85.84%117.98K	-98.32%12.44K	-65.22%106.64K	119.88%26.91K	64.14%-28.01K	196.65%833.39K	104.40%740.15K	5,969.93%306.65K	86.33%-135.3K
-Change in receivables	-131.16%-105.67K	9.71%606.16K	7.83%72.59K	871.71%208.55K	-108.70%-14.03K	12.12%339.05K	-14.24%552.51K	-91.07%67.32K	108.15%21.46K	174.62%161.34K
-Change in inventory	-22.20%60.82K	-129.48%-160.39K	-125.30%-29.89K	-86.20%57.46K	-294.68%-266.14K	161.56%78.17K	257.37%544.11K	445.06%118.14K	93.20%416.26K	158.43%136.71K
-Change in payables and accrued expense	112.75%55.23K	-218.55%-381.29K	-102.57%-16.68K	-89.55%-253.51K	175.39%321.95K	-107.57%-433.06K	89.86%-119.7K	265.29%649.74K	-381.72%-133.74K	20.22%-427.07K
-Change in other current liabilities	-175.79%-12.04K	160.48%76.62K	95.10%-5.37K	1,696.16%93.01K	-7.74%-6.65K	12.80%-4.37K	-528.12%-126.69K	-2,431.20%-109.68K	-18.56%-5.83K	-35.83%-6.18K
-Change in other working capital	171.50%5.58K	-37.20%-23.12K	-156.19%-8.22K	-86.77%1.12K	-7,589.72%-8.23K	80.43%-7.8K	-142.16%-16.85K	--14.63K	--8.5K	---107
Cash from discontinued investing activities
Operating cash flow	70.44%-34.44K	-335.87%-1.3M	-154.94%-261.91K	-391.15%-899.35K	87.84%-23.82K	-207.93%-116.52K	5,923.60%551.82K	-1.30%476.74K	-2.21%308.89K	78.35%-195.97K
Investing cash flow
Cash flow from continuing investing activities	576.62%24.1K	15.08%-382.58K	72.44%-13.75K	-2,064.65%-360.71K	98.62%-3.06K	97.44%-5.06K	8.17%-450.5K	34.59%-49.9K	131.34%18.36K	-270.45%-221.82K
Net PPE purchase and sale	-21,414.71%-21.95K	-175.79%-149.4K	94.50%-937	-3,561.28%-134K	-1,010.29%-14.36K	99.68%-102	-1,613.19%-54.17K	-1,231.27%-17.03K	-792.68%-3.66K	-94.14%-1.29K
Net investment purchase and sale	371.85%37.1K	42.43%-294.59K	77.73%-25.33K	-3,851.44%-255.81K	100.09%202	92.07%-13.65K	-0.44%-511.71K	-36.09%-113.73K	111.26%6.82K	-235.83%-232.62K
Cash from discontinued investing activities
Investing cash flow	576.62%24.1K	15.08%-382.58K	72.44%-13.75K	-2,064.65%-360.71K	98.62%-3.06K	97.44%-5.06K	8.17%-450.5K	34.59%-49.9K	131.34%18.36K	-270.45%-221.82K
Financing cash flow
Cash flow from continuing financing activities	1,461.38%24.22K	5,219.80%5.75M	589.05%11.12K	331,172.47%5.75M	-2.43K	-1.78K	483.28%108.17K	54.16%-2.27K	71.45%-1.74K
Net issuance payments of debt	----	--0	--0	--0	----	----	-29.41%-34.04K	--0	--0	----
Net common stock issuance	----	----	----	--5.75M	----	----	----	----	--0	----
Cash dividends paid	--0	--0	--0	--0	--0	--0	--0	--0	--0	----
Net other financing activities	--26.93K	3,742.13%5.76M	----	----	----	----	7,912.50%150K	----	----	----
Cash from discontinued financing activities
Financing cash flow	1,461.38%24.22K	5,219.80%5.75M	589.05%11.12K	331,172.47%5.75M	---2.43K	---1.78K	483.28%108.17K	54.16%-2.27K	71.45%-1.74K	----
Net cash flow
Beginning cash position	179.84%5.93M	-0.24%2.12M	320.37%6.15M	31.21%1.76M	6.99%1.97M	-0.24%2.12M	-23.81%2.12M	-14.00%1.46M	-9.60%1.34M	-25.47%1.84M
Current changes in cash	111.25%13.88K	1,842.87%4.07M	-162.31%-264.55K	1,278.54%4.49M	90.41%-29.31K	47.50%-123.35K	141.11%209.49K	5.68%424.56K	29.58%325.52K	68.61%-305.61K
Effect of exchange rate changes	-397.91%-111.03K	-21.04%-259.68K	-79.75%47K	51.29%-99.16K	6.63%-185.22K	50.03%-22.3K	-39.19%-214.55K	966.13%232.03K	-507.38%-203.58K	-984.03%-198.38K
End cash Position	195.57%5.83M	179.84%5.93M	179.84%5.93M	320.37%6.15M	31.21%1.76M	6.99%1.97M	-0.24%2.12M	-0.24%2.12M	-14.00%1.46M	-9.60%1.34M
Free cash flow	51.65%-56.39K	-391.57%-1.45M	-157.18%-262.85K	-438.55%-1.03M	80.65%-38.18K	-66.53%-116.62K	8,195.57%497.65K	-4.57%459.71K	-3.24%305.23K	78.22%-197.26K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall